CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (96,384)	$ (65,637)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	7,070	3,428
Stock-based compensation	25,324	18,557
Change in right-of-use asset	2,075	1,292
Interest expense	290	36
Amortization of debt issuance costs and debt discount	104	250
Change in fair value of warrant liabilities	(7,350)	406
Inventory write down	894	866
Provision for doubtful accounts	9	0
Gain from disposal of property and equipment	(100)	0
Changes in operating assets and liabilities:
Accounts receivable	(69)	(4,378)
Inventory	(14,249)	(2,551)
Prepaid expenses and other assets	(1,540)	42
Accounts payable	3,225	(2,707)
Accrued and other liabilities	(158)	7,060
Operating lease liability	(2,431)	(1,770)
Net cash used in operating activities	(83,290)	(45,106)
CASH FLOWS FROM INVESTING ACTIVITIES
Proceeds from sale of property & equipment	275	0
Purchases of property and equipment	(2,353)	(1,774)
Net cash used in investing activities	(2,078)	(1,774)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from the merger and private offering	0	291,454
Payment of offering costs	0	(27,124)
Repayment of debt	0	(7,000)
Proceeds from issuance of promissory notes to related parties	0	5,000
Repayment of promissory notes to related parties	0	(5,000)
Repurchase of common stock	(46)	(43)
Proceeds from exercise of stock options	398	539
Proceeds from borrowings, net of debt discount and issuance costs	19,077	0
Proceeds from the issuance of common stock under at-the-market offering, net of commissions and fees	16,322	0
At-the-market offering costs for the issuance of common stock	(278)	0
Taxes paid related to net share settlement of restricted stock awards	(59)	0
Net cash provided by financing activities	35,414	257,826
Effect of exchange rates on cash and cash equivalents	(175)	0
Net increase (decrease) in cash, cash equivalents and restricted cash	(50,129)	210,946
Cash, cash equivalents and restricted cash at beginning of period	184,656	12,642
Cash, cash equivalents and restricted cash at end of period	134,527	223,588
SUPPLEMENTAL DISCLOSURES OF OPERATING ACTIVITIES:
Cash paid for interest	750	635
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION:
Property and equipment purchases included in accounts payable and accrued liabilities	45	334
Private placement warrants acquired as part of the merger	0	19,377
Issuance of redeemable convertible preferred stock upon exercise of warrants	0	58,097
Conversion of redeemable convertible preferred stock to common stock	0	97,322
Right-of-use assets obtained in exchange for operating lease liability	571	0
Unpaid at-the-market offering costs	$ 267	$ 0